期刊文献+

老年患者血小板膜糖蛋白Ⅲa基因血小板抗原T/C多态性与阿司匹林抵抗的研究 被引量:3

Platelet glycoproteinⅢa gene platelet antigen T/C polymorphisms and aspirin resistance in aged patients
下载PDF
导出
摘要 目的分析中国老年汉族人群中血小板膜糖蛋白(GP)Ⅲa(Leu33 Pro)基因血小板抗原(PLA)的T/C多态性与阿司匹林抵抗(AR)的关系。方法选择长期服用阿司匹林患者共432例,分为AR组250例,阿司匹林敏感组(AS组)182例,检测花生四烯酸(AA)诱导的血小板聚集率,DNA测定GPⅢa基因(Leu33Pro)PLA(T/C)多态性。结果 AR组PLA1/A1基因型240例,PLA1/A2基因型10例;AS组均为PLA1/A1基因型。PLA2基因型在AR组中的发生率为4.0%,在总人群中的发生率为2.3%,差异有统计学意义(P<0.05)。结论中国老年汉族人群中,AR患者的PLA1/A2基因型表达高于AS患者,考虑PLA1/A2基因型与中国老年汉族人发生AR有关。 Objective To study the relation between glycoprotein Ⅲ a [GPⅢ a (Leu33Pro)] T/C polymorphisms and aspirin resistance(AR)in aged Chinese. Methods Four hundred and thirtytwo aged Chinese undergoing chronic aspirin therapy were divided into AR group(n:250) and aspirin sensitive(AS) group (n = 182). Arachnoid acid induced platelet aggregation and GPⅢ a (Leu33Pro)T/C polymorphisms were detected with DNA. Results The PLA1/A1 and PLA1/A2 genotype heterozygotes were detected in 240 and 10 subjects, respectively. The PLA1/A1 genotype hornozygotes were only detected in AS group. The prevalence of PLA2 genotype was 4.0% and 2.3% in the AR group and in the total population,respectively(P〈0.05). Conclusion The prevalence of PLA1/A2 genotype is higher in AR group than in AS group,which is related with AR in aged Chinese.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第3期287-289,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 阿司匹林 整合素Β3 抗原 人血小板 血小板聚集 多态性 限制性片段长度 基因型 花生四烯酸类 aspirin integrin beta3 antigens, human platelet platelet aggregation polymorphism, restriction fragment length genotype arachidonic acids
  • 相关文献

参考文献9

  • 1Feher A,Pusch G, Harang G, et al. Aspirin resistance in cerebrovaseular patients. Int J Cardiol,2011,152 : 111-112.
  • 2Hanjis C, Frishman WH, Lerner RG, et al. Aspirin resistance: Mechanisms and clinical implications. Cardiol Rev, 2006, 14: 18-25.
  • 3Cattaneo M, Aspirin and clopidogrel: Efficacy, safety and the issue of drug resistance. Arterioseler Thromb Vase Biol, 2004, 24:1980 1987.
  • 4Campbell CL,Steinhubl SR. Variability in response to aspirin: Do we understand the clinical relevance? J Thromb Haemost, 2005,3:665 -669.
  • 5Sanderson S, EmeryJ, Baglin T, et al. Narrative review: Aspi tin resistance and its clinical implications. Ann Intern Med, 2005,142:37-0380.
  • 6Berent R,Sinzinger H. Aspirin resistance? A few critical con siderations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease and therapeutic conse quences. Vasa, 2011,40 : 429 -438.
  • 7Szczeklik A. Reasons for aspirin resistance. Thromb Haemosl, 2011,105:1124.
  • 8Lee YK, Kim HS, Park JY, et al. Incidence of aspirin resistance in the patient group of a university hospital in Korea. Korean J Lab Med,2008,28:251-257.
  • 9Chen CH,Lo YK,Ke D,et al. Platelet glycoprotein Ⅰ a C807T. Ⅰb C355OT. and Ⅲ a PL polymorphisms and ischemic stroke in young Taiwan Residents. J Neurol Sci, 2004,227 : 1- 5.

同被引文献14

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部